Therapy of chronic urticaria: A simple, modern approach

Annals of Allergy, Asthma and Immunology

Volumn 112, Issue 5, 2014, Pages 419-425

  Kaplan, Allen P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; CREATININE; CYCLOSPORIN; DAPSONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; OMALIZUMAB; SALAZOSULFAPYRIDINE;

ABSENCE OF SIDE EFFECTS; BINDING ASSAY; BLOOD PRESSURE MEASUREMENT; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LOW DRUG DOSE; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ANTI-ALLERGIC AGENTS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; CYCLOSPORINE; HISTAMINE ANTAGONISTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; URTICARIA;

EID: 84899514877     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2014.02.014     Document Type: Review

References (98)

1. M. Greaves Chronic urticaria N Engl J Med 332 1995 1767 1772
2. T. Zuberbier, R. Asero, and C. Bindslev-Jensen et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria Allergy 64 2009 1417 1426
3. A. Kaplan Chronic urticaria: pathogenesis and treatment J Allergy Clin Immunol 114 2004 465 474
4. M. Maurer, C. Bindslev-Jensen, and A. Gimenez-Arnau et al. Chronic idiopathic urticaria (CIU) is no longer idiopathic: time for an update Br J Dermatol 168 2013 455 456
5. R. Barlow, E. Ross, and D. MacDonald et al. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria Br J Dermatol 131 1994 341 347
6. Y. Sun, Z. Zhao, and X. Meng et al. Cellular basis of itch sensation Science 325 2009 1531 1534
7. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis and management of urticaria: the 2013 revision and update. Allergy. In press.
8. Berastem J, Lang D, Khan D. The diagnosis and management of acute and chronic urticarias, 2013 update. J Allergy Clin Immunol. In press.
9. A. Leznoff, R. Josse, and J. Denburg et al. Association of chronic urticaria and angioedema with thyroid autoim Arch Dermatol 119 1983 636 640
10. A. Leznoff, and G. Sussman Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients J Allergy Clin Immunol 84 1989 66 71
11. Y. Kikuchi, T. Fann, and A. Kaplan Antithyroid antibodies in chronic urticaria and angioedema J Allergy Clin Immunol 112 2003 218
12. M. Sanchez-Borges, R. Asero, and I. Ansotengui et al. Diagnosis and treatment of urticaria and angioedema: worldwide perspective World Allergy Organ J 5 2012 125 147
13. R. Viswanathan, M. Biagtan, and S. Mathur The role of autoimmune testing in chronic idiopathic urticaria Ann Allergy Asthma Immunol 108 2012 337 341
14. A. Kaplan, and M. Greaves Pathogenesis of chronic urticaria Clin Exp Allergy 39 2009 777 787
15. S. Natbony, M. Phillips, and J. Elias et al. Histologic studies of chronic idiopathic urticaria J Allergy Clin Immunol 71 1983 177 183
16. S. Ying, Y. Kikuchi, and Q. Meng et al. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction J Allergy Immunol 109 2002 694 700
17. G. Konstantinou, R. Asero, and M. Ferrer et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria Allergy 68 2013 27 36
18. L. Brodell, L. Beck, and S.S. Saini Pathophysiology of chronic urticaria Ann Allergy Asthma Immunol 100 2008 291 297
19. C. Grattan, G. Dawn, and S. Gibbs et al. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity Clin Exp Allergy 33 2003 337 341
20. B. Vonakis, K. Vasagar, and S.J. Gibbons et al. Basophil FcεRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria J Allergy Clin Immunol 119 2007 441 448
21. J. Eckman, R. Hamilton, and L. Gober et al. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies J Invest Dermatol 128 2008 1956 1963
22. A. Kobza-Black Physical and cholinergic urticarias A.P. Kaplan, M. Greaves, Urticaria and Angioedema 2009 Informa Health Care New York, NY 181 216
23. R. Confino-Cohen, G. Chodick, and V. Shalev et al. Chronic urticaria and autoimmunity: associations found in a large population study J Allergy Clin Immunol 128 2012 1307 1313
24. S. Altrichter, H. Peter, and D. Pisarevskaja et al. IgE mediated autoallergy against thyroid peroxidase-a novel pathomechanism of chronic spontaneous urticaria? PLoS One 6 2011 e14794
25. M. Hide, D. Francis, and C. Grattan et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria N Engl J Med 328 1993 1599 1604
26. G. Du Toit, R. Prescott, and P. Lawrence et al. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria Ann Allergy Asthma Immunol 96 2006 341 344
27. L. Brunetti, R. Francavilla, and V. Miniello et al. High prevalence of autoimmune urticaria in children with chronic urticaria J Allergy Clin Immunol 114 2004 922 927
28. N. Niimi, D. Francis, and F. Kermani et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria J Invest Dermatol 106 1996 1001 1006
29. Y. Kikuchi, and A. Kaplan Mechanisms of autoimmune activation of basophils in chronic urticaria J Allergy Clin Immunol 107 2001 1056 1062
30. Y. Kikuchi, and A. Kaplan A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria J Allergy Clin Immunol 109 2002 114 118
31. S. Soundararajan, Y. Kikuchi, and K. Joseph et al. Isolation of the pathogenic IgG subclasses in chronic autoimmune urticaria: evidence that IgG1, IgG3, and IgG4 contain antireceptor antibodies that activate basophils while IgG2 is inactive J Allergy Clin Immunol 145 2005 815 821
32. A. Kaplan, and A. Finn Autoimmunity and the etiology of chronic urticaria Can J Allergy Clin Immunol 4 1999 286 292
33. B. Gruber, M. Baeza, and M. Marchese et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes J Invest Dermatol 90 1988 213 217
34. C. Grattan, D. Francis, and M. Hide et al. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria Clin Exp Allergy 21 1991 695 704
35. M. Horn, T. Gerster, and B. Ochensberger et al. Human anti-FcεRIalpha autoantibodies isolated from healthy donors cross-react with tetanus toxoid Eur J Immunol 29 1999 1139 1148
36. K. Vasagar, B. Vonakis, and L. Gober et al. Evidence of in vivo basophil activation in chronic idiopathic urticaria Clin Exp Allergy 36 2006 770 776
37. J. Eckman, R. Hamilton, and S. Saini Independent evaluation of a commercial test for "autoimmune" urticaria in normal and chronic urticaria subjects J Invest Dermatol 129 2009 1584 1586
38. E. Fiebiger, F. Hammerschmid, and G. Stingl et al. Anti-FcεRIalpha autoantibodies in autoimmune-mediated disorders: identification of a structure-function relationship J Clin Invest 101 1998 243 251
39. C. Cho, S. Stutes, and M. Altrich et al. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders Ann Allergy Asthma Immunol 110 2013 29 33
40. A. Kaplan, and K. Joseph Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol 120 2007 729 730
41. K. Hancock, S. Narang, and S. attabhi et al. False positive reactivity of recombinant, diagnostic, glycoproteins produced in High Five insect cells: effect of glycosylation J Immunol Methods 330 2008 130 136
42. C. Grattan, T. Wallington, and R. Warin et al. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation Br J Dermatol 114 1986 583 590
43. M. Altrich, J. Halsey, and L. Altman Comparison of the in vivo autologous skin test with in vitro diagnostic tests for diagnosis of chronic autoimmune urticaria Allergy Asthma Proc 30 2009 28 34
44. C. Grattan, A. Boon, and R. Eady et al. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions Int Arch Allergy Immunol 93 1990 198 204
45. M. Platzer, C. Grattan, and L. Poulsen et al. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients Allergy 60 2005 1152 1156
46. R. Powell, G. Du Toit, and N. Siddique et al. British Society for Allergy and Clinical Immunology (BSACI). BSACI guidelines for the management of chronic urticaria and angio-oedema Clin Exp Allergy 37 2007 631 650
47. A. Wanderer, and E. Ellis Treatment of cold urticaria with cyproheptadine J Allergy Clin Immunol 48 1971 366 371
48. A. Wanderer, J. St Pierre, and E. Ellis Primary acquired cold urticaria: double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo Arch Dermatol 131 1977 1375 1377
49. P. Gorevic, and A. Kaplan The physical urticarias Int J Dermatol 19 1980 417 435
50. A. Kaplan Urticaria and angioedema: etiology, pathogenesis, and treatment A. Kaplan, Allergic Diseases 1985 Churchill Livingstone London, England 439 471
51. A. Kaplan Clinical practice: chronic urticaria and angioedema N Engl J Med 346 2002 175 179
52. J. Weiler, J. Bloomfield, and G. Woodworth et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator Ann Intern Med 132 2000 354 363
53. J. Verster, E. Volkerts, and A. van Oosterwijck et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood J Allergy Clin Immunol 111 2003 623 627
54. J. Ramaekers, and J. O'Hanlon Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing Eur J Clin Pharmacol 47 1994 261 266
55. M. Church, M. Maurer, and F. Simons et al. Risk of first-generation H(1)-antihistamines: a GA(2)LEN position paper Allergy 65 2010 459 466
56. A. Kaplan What the first 10,000 patients with chronic urticaria have taught me: a personal journey J Allergy Clin Immunol 123 2009 713 717
57. F. Siebenhaar, F. Degener, and T. Zuberbier et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study J Allergy Clin Immunol 123 2009 672 679
58. M. Staevska, T. Popov, and T. Kralimarkova et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria J Allergy Clin Immunol 125 2010 676 682
59. B. Bender, S. Berning, and R. Dudden et al. Sedation and performance impairment of diphenhydramine and second-generation antihistamines: a meta-analysis J Allergy Clin Immunol 111 2003 770 776
60. J. Park, J. Godbold, and D. Chung et al. Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions J Allergy Clin Immunol 128 2011 1127 1128
61. S. Bagenstose, L. Levin, and J. Bernstein The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results J Allergy Clin Immunol 113 2004 134 140
62. A. Erbagci The leucotriene antagonist montelukast in the treatment of chronic urticaria: a single-blind placebo-controlled, crossover clinical study J Allergy Clin Immunol 110 2002 484 488
63. A. Reimers, C. Pichler, and A. Helbling et al. Zafirlukast has no beneficial effects in the treatment of chronic urticaria Clin Exp Allergy 32 2002 1763 1768
64. G. Di Lorenzo, M. Pacor, and P. Mansueto et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria J Allergy Clin Immunol 114 2004 619 625
65. K. Saag, L. Criswell, and K. Sems et al. Low-dose corticosteroids in rheumatoid arthritis: a meta-analysis of their moderate-term effectiveness Arthritis Rheum 39 1996 1818 1825
66. T. Pincus, and I. Castrejon Effective initial and long-term prednisone in doses of less than 5 mg/day to treat rheumatoid arthritis: documentation using a patient self-report Multidimensional Health Assessment Questionnaire (MDHAQ) Bull NYU Hosp Jt Dis 70 suppl 1 2012 14 20
67. J. Wisnieski, A. Baer, and J. Christensen et al. Hypocomplementemic urticarial vasculitis syndrome: clinical and serologic findings in 18 patients Medicine 74 1995 24 41
68. G. Reeves, M. Boyle, and J. Bonfield et al. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation Intern Med J 34 2004 182 186
69. R. Criado, P. Criado, and J. Martins et al. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features J Dermatolog Treat 19 2008 92 96
70. B. Engin, and M. Ozdemir Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria J Eur Acad Dermatol Venereol 22 2008 481 486
71. I. Boehm, R. Bauer, and T. Bieber Urticaria treated with dapsone Allergy 54 1999 765 766
72. L. McGirt, K. Vasagar, and L. Gober et al. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine Arch Dermatol 142 2006 1337 1342
73. A. Jaffer Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria J Allergy Clin Immunol 88 1991 964 965
74. E. Toppe, N. Haas, and B. Henz Neutrophilic urticaria: clinical features, histological changes and possible mechanisms Br J Dermatol 138 1998 248 253
75. R. Sabroe, E. Poon, and G. Orchard et al. Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies J Allergy Clin Immunol 103 1999 484 493
76. B. O'Donnell, R. Barr, and A. Black et al. Intravenous immunoglobulin in autoimmune chronic urticaria Br J Dermatol 138 1998 101 106
77. H. Mitzel-Kaoukhov, P. Staubach, and T. Muller-Brenne Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria Ann Allergy Asthma Immunol 104 2010 253 258
78. J. Gach, R. Sabroe, and M. Greaves et al. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases Br J Dermatol 145 2001 340 343
79. C. Grattan, D. Francis, and N. Slater et al. Plasmapheresis for severe, unremitting, chronic urticaria Lancet 339 1992 1078 1080
80. A. Marsland, S. Soundararajan, and K. Joseph et al. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria Clin Exp Immunol 35 2005 554 559
81. C. Stellato, A. de Paulis, and A. Ciccarelli et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells J Invest Dermatol 98 1992 800 804
82. C. Grattan, B. O'Donnell, and D. Francis et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria Br J Dermatol 143 2000 365 372
83. E. Toubi, A. Blant, and A. Kessel et al. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria Allergy 52 1997 312 316
84. A. Kessel, and E. Toubi Cyclosporine A in severe chronic urticaria: the option for long-term therapy Allergy 65 2010 1478 1482
85. S. Hollander, S. Joo, and H. Wedner Factors that predict the success of cyclosporine treatment for chronic urticaria Ann Allergy Asthma Immunol 107 2011 523 528
86. D. Doshi, and M. Weinberger Experience with cyclosporine in children with chronic idiopathic urticaria Pediatr Dermatol 26 2009 409 413
87. S. Spector, and R. Tan Effect of omalizumab on patients with chronic urticaria Ann Allergy Asthma Immunol 99 2007 190 193
88. M. Sands, J. Blume, and S. Schwartz Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab J Allergy Clin Immunol 120 2007 979 981
89. A. Kaplan, K. Joseph, and R. Maykut et al. Treatment of chronic autoimmune urticaria with omalizumab J Allergy Clin Immunol 122 2008 569 573
90. 1-antihistamine-refractory chronic idiopathic urticaria J Allergy Clin Immunol 128 2011 567 573
91. M. Maurer, S. Altrichter, and T. Bieber et al. Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase J Allergy Clin Immunol 128 2011 202 209
92. M. Maurer, K. Rosen, and H. Hsieh et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria N Eng J Med 368 2013 924 935
93. A. Kaplan, D. Ledford, and M. Ashby et al. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy J Allergy Clin Immunol 132 2013 101 109
94. M. Ferrer, P. Gamboa, and M. Sanz et al. Omalizumab is effective in non-autoimmune urticaria J Allergy Clin Immunol 127 2011 1300 1302
95. D. MacGlashan Jr., and S. Saini Omalizumab increases the intrinsic sensitivity of human basophils o IgE-mediated stimulation J Allergy Clin Immunol 132 2013 906 911
96. G. Gomez, S. Jogie-Brahim, and M. Shima et al. Omalizumab reverses the phenotypic and functional effects of IgE-enhanced FcεRI on human skin mast cells J Immunol 179 2007 1353 1361
97. F. Zhang, H. Liu, and A. Irwanto et al. HLA-B*13:01 and the dapsone hypersensitivity syndrome N Engl J Med 369 2013 1620 1628
98. A. Kaplan Treatment of chronic spontaneous urticaria Allergy Asthma Immunol Res 4 2012 326 331